Galera Therapeutics, Inc.   (NASDAQ:GRTX)

1.67    $-0.10   -5.65%
Market open   Sunday, May 22 2022 13:57 PM

Galera Therapeutics, Inc. Chart

GRTX Stock Price Today

Galera Therapeutics, Inc. (GRTX) stock plummeted over -5.65% intraday to trade at $1.67 a share on NASDAQ. The stock opened with a gain of 1.13% at $1.79 and touched an intraday high of $1.80, rising 1.69% against the last close of $1.77. The stock went to a low of $1.62 during the session.

Stock Snapshot

1.77
Prev. Close
1.79
Open
36.82M
Market Cap
26.45M
Number of Shares
1.62
day Low
1.80
Day High
1.67
-
P/E ratio
2.55%
Free Float in %
-3.30
EPS (TTM)
-2.19
Book Value per Share
3.23
Cash Flow per Share
100762
Volume

Galera Therapeutics, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$1.79$1.67$1.80$1.62120,300
2022-05-19$1.69$1.77$1.79$1.65106,600
2022-05-18$1.66$1.70$1.79$1.57115,800
2022-05-17$1.76$1.69$1.80$1.58223,000
2022-05-16$1.53$1.71$1.71$1.42509,900
2022-05-13$1.25$1.51$1.52$1.20272,300
2022-05-12$1.18$1.24$1.30$1.15198,600
2022-05-11$1.35$1.25$1.37$1.23159,800
2022-05-10$1.36$1.37$1.47$1.3583,400
2022-05-09$1.52$1.41$1.57$1.36137,500
2022-05-06$1.55$1.45$1.56$1.38177,100

Contact Details

2 West Liberty Boulevard
Suite 100
Malvern, PA 19355
United States
https://www.galeratx.com
610 725 1500

About Company

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Frequently Asked Questions

What is the current Galera Therapeutics, Inc. (GRTX) stock price?

Galera Therapeutics, Inc. (NASDAQ: GRTX) stock price is $1.67 as of the last check on Sunday, May 22 2022. During the trading session, GRTX stock reached the peak price of $1.80 while $1.62 was the lowest point it dropped to.

GRTX's industry and sector of operation?

The NASDAQ listed GRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer.

Who are the executives of GRTX?

Dr. J. Mel Sorensen
CEO, Pres & Director

Dr. Robert A. Beardsley M.B.A., Ph.D.
Co-Founder & COO

Mr. Christopher Degnan
CFO & Sec.

Mr. Joel F. Sussman
Chief Accounting Officer


What is the GRTX stock price today?

GRTX stock is trading at $1.67 today, which is $-0.10 or -5.65% lower than its previous close of $1.77. GRTX's current trading price is -84.52% lower than its 52-week high of $10.79 where as its distance from 52-week low of $1.15 is 45.22%.

How many employees does GRTX have?

Number of GRTX employees currently stands at 38. GRTX operates from 2 West Liberty Boulevard
Suite 100
Malvern, PA 19355
United States.

Link for GRTX official website?


How do I contact GRTX?

GRTX could be contacted at 2 West Liberty Boulevard
Suite 100
Malvern, PA 19355
United States, or at phone # 610 725 1500 and can also be accessed through its website: https://www.galeratx.com

How many shares of GRTX are traded daily?

GRTX stock volume so far today is 100762 shares while in the previous session number of GRTX shares traded was 120300. The average number of GRTX shares traded daily for last 3 months was 226360.

How much did GRTX change today?

The percentage change in GRTX stock occurred in the recent session was -5.65% while the dollar amount for the price change in GRTX stock was $-0.10.

What price range GRTX stock been trading in?

In the recent session, the day high for GRTX stock was $1.80 while the low for GRTX stock touched on the day was $1.62.

What is the market cap of GRTX currently?

The market value of GRTX currently stands at $36.82M with its latest stock price at $1.67 and 26.45M of its shares outstanding.